The immune system and gastrointestinal stromal tumor
Authors:
- Monica T. Garcia-BuitragoMGMonica T. Garcia-Buitrago
- Jonathan C. TrentJTJonathan C. Trent
- Andrew E. RosenbergARAndrew E. Rosenberg
- 1 July 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 27 (4) , 338-342
Abstract
This article reviews the current literature on tumor-infiltrating immune cells in gastrointestinal stromal tumor (GIST), and the current status and prospects of effective immunotherapeutic strategies. Tumor-infiltrating immune cells populate the microenvironment of GISTs; the most numerous are tumor-associated macrophages (TAMs) and CD3 T cells. TAMs have not been shown to have a relationship with the biological behavior of GISTs; however, the number of CD3 T cells correlates with better outcomes. The prognostic significance of tumor-infiltrating neutrophils, natural killer cells, CD4 T cells, CD8 T cells, and Treg cells remains unknown.Imatinib mesylate achieves a clinical response in 80% of patients with GIST. Its antitumor mechanism is partially immune mediated. The combination of imatinib and interferon-α has been shown to be effective against GIST - it eradicates tumor cells including those that are drug resistant. Preclinical trials including cytotoxic T lymphocyte-associated antigen 4 blockade, anti-KIT antibody, and the generation of designer T cells have shown promising therapeutic effect in animal models of GIST. GIST contains many tumor-infiltrating immune cells and should be susceptible to immunotherapy; early clinical and preclinical trials have shown promising results that should lead to new investigations and effective forms of direct and synergistic therapies.Keywords
This publication has 17 references indexed in Scilit:
- Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: A preliminary studyOral Oncology, 2015
- The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysisBreast Cancer Research and Treatment, 2014
- Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer ProgressionFrontiers in Immunology, 2014
- Managing GIST in the imatinib era: optimization of adjuvant therapyExpert Review of Anticancer Therapy, 2014
- Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cellsClinical and Experimental Immunology, 2014
- Myeloid-derived cells are key targets of tumor immunotherapyOncoImmunology, 2014
- Increased pro-angiogenic factors, infiltrating neutrophils and CD163+ macrophages in bronchoalveolar lavage fluid from lung cancer patientsInternational Immunopharmacology, 2014
- Gastrointestinal Stromal TumorsHematology/Oncology Clinics of North America, 2013
- Gastrointestinal Stromal TumorsHematology/Oncology Clinics of North America, 2013
- Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal TumorsCancer Research, 2013